Sign In
Buy HROW
$33.32
+0.460 (+1.40%)
At Close: Jun 03, 2026
Harrow's Internal $100 Price Target Is Ambitious, But New Bloomberg Data Backs It Up
05:47pm, Friday, 11'th Jul 2025
Harrow's new 3-year share-based compensation plan sets ambitious share price targets, with awards at $50, $60, $75, and $100. The two previous plan targets were quickly surpassed, suggesting managemen
Harrow: Immense Upside Potential
02:52pm, Wednesday, 09'th Jul 2025
Harrow, Inc. is a strong swing trade in the $20s, with long-term upside as sales and new product launches drive sustained profits. Recent licensing of BYQLOVI and the VEVYE Access for All program are
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. - HROW
03:58pm, Monday, 07'th Jul 2025
NEW YORK , July 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Harrow, Inc. ("Harrow" or the "Company") (NASDAQ: HROW). Such investors are advised to contact
HROW Investors Have Opportunity to Join Harrow, Inc. Fraud Investigation with the Schall Law Firm
08:50pm, Sunday, 06'th Jul 2025
LOS ANGELES--(BUSINESS WIRE)---- $HROW--HROW Investors Have Opportunity to Join Harrow, Inc. Fraud Investigation with the Schall Law Firm.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
10:00am, Sunday, 06'th Jul 2025
NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Harrow, Inc. (“Harrow” or the “Company”) (NASDAQ: HROW). Such investors are advised
Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications
07:00am, Wednesday, 18'th Jun 2025
NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that Mike Biega has joined Harrow as Vice President of Investor Relat
I Am Swimming In Dividends With +7% Yields
08:30am, Friday, 13'th Jun 2025
Winning in gold requires patience and a steady strategy to use the environment to your advantage. The same holds true for investing. Focus on steady dividends over chasing market hype or short-term ga
NASHVILLE, Tenn. & TAIPEI, Taiwan--(BUSINESS WIRE)---- $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, and Taiwan-based Formosa Pharmaceuticals (“Formosa”, 6
Harrow: Epic Growth & Operating Leverage On Full Display
03:20pm, Wednesday, 28'th May 2025
Harrow has successfully leveraged its compounding pharmacy roots to drive rapid branded drug growth. Revenue has grown at a steady 40% CAGR for a decade & EBITDA has grown even more sharply. Managemen
Harrow to Present at Two Investor Conferences in May
07:00am, Wednesday, 14'th May 2025
NASHVILLE, Tenn.--(BUSINESS WIRE)---- $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following two inves
Harrow, Inc. (HROW) Q1 2025 Earnings Call Transcript
06:17pm, Saturday, 10'th May 2025
Harrow, Inc. (NASDAQ:HROW ) Q1 2025 Results Conference Call May 9, 2025 8:00 AM ET Company Participants Jamie Webb - Director, Communications & IR Mark Baum - CEO Andrew Boll - CFO Conference Call Par
Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates
06:10pm, Thursday, 08'th May 2025
Harrow (HROW) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of $0.02. This compares to loss of $0.28 per share a year ago.
Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025
07:00am, Monday, 05'th May 2025
NASHVILLE, Tenn.--(BUSINESS WIRE)---- $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its financial results for the first qua
What Recession? I'm Swimming In Dividends
07:35am, Tuesday, 29'th Apr 2025
What Recession? I'm Swimming In Dividends
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC.
10:00am, Thursday, 24'th Apr 2025
BERWYN, Pa. , April 24, 2025 /PRNewswire/ -- Nordic Pharma, Inc., a subsidiary of Nordic Group B.V.
